HUTCHMED’s Post

“Every single patient can teach us important lessons”. This landmark paper, published in the NEJM in 2013, highlights several fundamental principles for the management of #CAR_T-cell_therapy and its life-threatening complications through the publication of the very first two cases of children with acute lymphoblastic leukemia treated with this approach. https://lnkd.in/dkM354pz

Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial https://lnkd.in/euG6HzPz

Understanding the signs and symptoms of acute lymphoblastic leukemia (ALL) in children is crucial for early detection and treatment. From anemia to swollen lymph nodes, recognizing these indicators can make a significant difference in the journey of young patients battling leukemia. #ALLSeries #LeukemiaChallenges #TreatmentStruggles #SupportNeeded

A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia https://lnkd.in/dRT-h22s

Guidelines for Venetoclax dosing in AML A Systematic Review of Venetoclax and Azacitidine: Effectiveness and Safety for Newly Diagnosed and Relapsed Acute Myeloid Leukemia Patients https://lnkd.in/de8ZVUmZ

Want to learn more about managing patients with chronic lymphocytic leukemia (CLL)? Watch this new sponsored video on updates in CLL: https://lnkd.in/dPK39eyV #LeukemiaAwareness #CLL

Did you know why today 9/22 as a world CML day? Around 95% of chronic myelogenous leukemia (CML) patients show DNA "swapped" also called translocation between “chromosomes 9 and 22”. Part of chromosome 9 goes to 22 and part of 22 goes to 9. However, Only 19% to 26% of patients with chronic myeloid leukemia (CML) discuss treatment decisions with their physician. CML shouldn’t be considered as “good cancer”, let’s remember this meaningful day 9/22 and dedicate to bridge the communication disparity between physicians and CML patients. https://lnkd.in/gA-HFEUg #SUNsurvey #922CMLDAY #WCMLD23 #CureCML #breakthesilence

Hairy cell leukemia coexistent with chronic lymphocytic leukemia https://lnkd.in/diVfFFXK

🌟 Encouraging News in Leukemia Research! 🌟 The AML-ViVA trial, funded by the Anticancer Fund, reveals promising outcomes for Acute Myeloid Leukemia (AML) patients above 60 who don't respond to initial chemotherapy. The combination of azacitidine, pioglitazone, and all-trans retinoic acid proves safe and effective. Let's join efforts in spreading awareness for improved treatment options in AML. Read more about this trial: https://lnkd.in/eGr8BNmE #anticancerfund #CancerResearch #acutemyeloidleukemia University Hospital Regensburg Gauthier B.